Results 151 to 160 of about 4,694,538 (359)

Evaluation of farm educational programs of electric power suppliers in the United States

, 1957
Elwood Forrest Olver
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

AN EVALUATION OF HIGH FLUX NUCLEAR SYSTEMS FOR RESEARCH WITHIN THE LIMITATIONS OF THE ATOMS-FOR-PEACE PROGRAM

, 1955
E.G. Silver, M.L. Batch, R.T. Breymeier, G. R. Dalton, J. Duncan, Fabian C. Foushée   +5 more
openalex   +1 more source

THE DEVELOPMENT AND EVALUATION OF SEVERAL PROGRAMMED TESTING METHODS [PDF]

, 1968
Robert L. Linn, Donald A. Rock, T. Anne Cleary   +2 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Feline-Ality™ in Real Life: A Program Evaluation. [PDF]

Animals (Basel), 2023
Darling S.
europepmc   +1 more source

Is home screening for bowel cancer a good idea?

Australian and New Zealand Journal of Public Health, 2003
Barbara‐Ann Adelstein, Lyndal Trevena, Alexandra Barratt, Glenn Salkeld   +3 more
doaj   +1 more source

Evaluasi Program Indonesia Pintar dalam Peningkatan Akses Pendidikan di Sekolah Menengah Pertama

Kelola: Jurnal Manajemen Pendidikan, 2019
This study aimed to evaluate the design, installation, process, product, and analysis of benefits and costs of the implementation of the Program Indonesia Pintar (PIP) in Improving Access to Education in SMP Negeri 7 Salatiga.
Wirastiani Binti Yusup, Bambang Ismanto, Wasitohadi Wasitohadi   +2 more
doaj  

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

Molecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho, Yubin Hah, Eunsik Yun, Hye In Ka, Aram Lee, Sora Han, Dawn Lee, Sung Wook Kim, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim   +11 more
wiley   +1 more source

Evaluation of Program Efficiency [PDF]

Public Health Reports (1896-1970), 1968
Getting Va, Rosenstock Im, W. Welch, Deniston Ol   +3 more
openaire   +3 more sources